A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

Uganda has recorded major gains against HIV, with significant declines in prevalence, new infections, and AIDS-related deaths, but emerging concerns among young people and persistent mother-to-child ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

A new study aims to better understand drug-use trends and barriers to health care in Vermont and New England. The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, ...

Today, Seema Sahay is Head of Division of Social Behavioural Research at the Indian Council of Medical Research, National Institute of Translational Virology & AIDS Research (NARI), Pune, India.

Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...

Merck on Wednesday said the Phase 3 study of the once-daily, two-drug single-tablet regimen met the success criterion for its primary efficacy hypothesis, showing non-inferiority to the three-drug ...